ArticleFrontiers in medicine2025
Enhancing multi-class neurodegenerative disease classification using deep learning and explainable local interpretable model-agnostic explanations.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Deep learning-based automated detection of endometrioid endometrial carcinoma in histopathology.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Alzheimer's disease (AD) and Parkinson's disease (PD) are two of the most prevalent neurodegenerative disorders, necessitating accurate diagnostic approaches for early detection and effective management. Methods: This study introduces two deep learning architectures, the Residual-based Attention Convolutional Neural Network (RbACNN) and the Inverted Residual-based Attention Convolutional Neural Network (IRbACNN), designed to enhance medical image classification for AD and PD diagnosis. By integrating self-attention mechanisms, these models improve feature extraction, enhance interpretability, and address the limitations of traditional deep learning methods. Additionally, explainable AI (XAI) techniques are incorporated to provide model transparency and improve clinical trust in automated diagnoses. Preprocessing steps such as histogram equalization and batch creation are applied to optimize image quality and balance the dataset. Results: The proposed models achieved an outstanding classification accuracy of 99.92%. Discussion: The results demonstrate that these architectures, in combination with XAI, facilitate early and precise diagnosis, thereby contributing to reducing the global burden of neurodegenerative diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.